Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05761951
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2023-02-27
Brief Title:
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 DKK1 Inhibitor Leap Therapeutics and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
Sponsor:
Organization:
MD Anderson Cancer Center